APA-referens (7:e uppl.)

Ray-Coquard, I. L., Savoye, A., Schiffler, C., Mouret-Reynier, M., Derbel, O., Kalbacher, E., . . . Tredan, O. (2024). Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma. Nature Communications, 15(1), . https://doi.org/10.1038/s41467-024-46999-x

Chicago-referens (17:e uppl.)

Ray-Coquard, Isabelle L., et al. "Neoadjuvant and Adjuvant Pembrolizumab in Advanced High-grade Serous Carcinoma." Nature Communications 15, no. 1 (2024). https://doi.org/10.1038/s41467-024-46999-x.

MLA-referens (9:e uppl.)

Ray-Coquard, Isabelle L., et al. "Neoadjuvant and Adjuvant Pembrolizumab in Advanced High-grade Serous Carcinoma." Nature Communications, vol. 15, no. 1, 2024, https://doi.org/10.1038/s41467-024-46999-x.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.